SCHEMBL3218002

SCHEMBL3218002

O=S(=O)(c1cccc(Cl)c1)C1CCN(c2ccc(C(F)(F)F)cn2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 1/20 0.52
L3MBTL1 Q9Y468 3/20 0.51
ELOVL6 Q9H5J4 1/20 0.51
KDM4E B2RXH2 2/20 0.50
ABL1 P00519 1/20 0.50
LMNA P02545 1/20 0.50
CA12 O43570 4/20 0.48
CA1 P00915 4/20 0.48
CA2 P00918 4/20 0.48
CA4 P22748 4/20 0.48
CA7 P43166 4/20 0.48
CA9 Q16790 4/20 0.48
TRPV1 Q8NER1 2/20 0.48
CTSS P25774 1/20 0.48
DGAT1 O75907 1/20 0.46
GAA P10253 1/20 0.46
SMO Q99835 1/20 0.46
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3207424 0.87 L3MBTL1 (0.63) GPR119L3MBTL1ELOVL6KDM4EABL1
SCHEMBL3216395 0.86 GPR119 (0.55) GPR119L3MBTL1KDM4EABL1LMNA
SCHEMBL3213659 0.83 LMNA (0.56) GPR119L3MBTL1KDM4EABL1LMNA
SCHEMBL3207477 0.80 GPR119 (0.61) GPR119L3MBTL1KDM4EABL1LMNA
SCHEMBL3215699 0.80 MEN1 (0.64) GPR119L3MBTL1LMNACYP2C9
SCHEMBL3223500 0.77 HSD11B1 (0.70) TRPV1
SCHEMBL3032201 0.74 GPR119 (0.54) GPR119KDM4EABL1LMNACA12
SCHEMBL3223542 0.74 CYP3A4 (0.45) ELOVL6CTSSCYP3A4
SCHEMBL16340230 0.73 L3MBTL1 (0.54) L3MBTL1KDM4ELMNAGAA
SCHEMBL759373 0.73 KDM4E (0.44) GPR119L3MBTL1KDM4EABL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 GPR119 626/4885L3MBTL1 1721/4885ELOVL6 571/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 GPR119 600/4885L3MBTL1 2300/4885ELOVL6 524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.